Our data established that cardiomyocyte-specific deletion of STAT3 in mice would lead to cardiac fibrosis, decreased capillary density, cardiac hypertrophy, and eventually impaired cardiac diastolic function partly by reducing the levels of PKG. Here, STAT3 is linked to cardiac hypertrophy.